Home › Pancreatic Cancer › Arizona › Phoenix
Pancreatic Cancer clinical trials in Phoenix, AZ
18 studies for Pancreatic Cancer are looking for participants at sites in and around Phoenix (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
RecruitingPhase 3
- City of Hope, Phoenix
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
RecruitingPhase 3
- Mayo Clinic Arizona, Phoenix
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
RecruitingPhase 3
- Mayo Clinic Arizona, Phoenix
Pancreatic Cancer Early Detection Consortium
RecruitingObservational studyHealthy volunteers welcome
- Mayo Clinic Arizona, Phoenix
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
RecruitingObservational study
- Mayo Clinic Hospital, Phoenix
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 3
- Mayo Clinic, Phoenix
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RecruitingPhase 2/3
- Mayo Clinic Hospital, Phoenix
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
RecruitingPhase 1
- Mayo Clinic Arizona, Phoenix
Pancreatic Cancer Detection Consortium
RecruitingObservational studyHealthy volunteers welcome
- Translational Genomics Research Institute, Phoenix
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecruitingPhase 1/2
- Mayo Clinic Hospital, Phoenix
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 2
- Mayo Clinic Arizona, Phoenix
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
RecruitingObservational study
- Mayo Clinic Hospital in Arizona, Phoenix
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
RecruitingPhase 1
- Mayo Clinic, Phoenix
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
RecruitingPhase 3
- Banner-University Medical Center Phoenix, Phoenix
- Arizona Center for Cancer Care - Phoenix, Phoenix
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
RecruitingPhase 3
- Cancer Center at Saint Joseph's, Phoenix
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
RecruitingObservational study
- Mayo Clinic Hospital in Arizona, Phoenix
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
RecruitingPhase 2
- Ohio State University-Telemedicine, Phoenix
PROMs After Pancreatectomy
RecruitingObservational study
- Mayo Clinic - Phoenix, Phoenix
About Pancreatic Cancer
The pancreas is a gland behind your stomach that produces insulin. Pancreatic cancer is hard to catch early. Find out about risk factors and symptoms.
More about Pancreatic Cancer on MedlinePlus
Pancreatic Cancer trials in other cities
- Houston, TX59 studies
- New York City, NY57 studies
- Boston, MA42 studies
- Nashville, TN39 studies
- Los Angeles, CA36 studies
- Arlington, VA33 studies
- San Antonio, TX33 studies
- St. Louis, MO33 studies
- Baltimore, MD30 studies
- Philadelphia, PA26 studies
- Tampa, FL26 studies
- San Diego, CA24 studies
Other studies in Phoenix
- Breast Cancer25 studies
- Colorectal Cancer24 studies
- Non-Small Cell Lung Cancer21 studies
- Metastatic Cancer19 studies
- Obesity19 studies
- Cancer (all types)17 studies
- Cardiovascular Disease16 studies
- Prostate Cancer16 studies
- Multiple Myeloma16 studies
- Heart Failure16 studies
- Alzheimer's Disease15 studies
- Acute Myeloid Leukemia13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.